Jorge Conde – Biografía

Jorge fue Chief Strategy Officer, Chief Financial Officer and Chief Product Officer para Syros Pharmaceuticals, y Co-Founder, Chief Executive Officer and Director de Knome. Jorge Conde se incorporó a Andreessen Horowitz en 2017.

Jorge Conde actualmente es

• General Partner, Lead of Biology, Computer Science and Engineering Investments at Andreessen Horowitz - View - Andreessen Horowitz org chart

• Director at Asimov - View - Asimov org chart

• Director at Cartography Biosciences - View - Cartography Biosciences org chart

• Director at Dyno Therapeutics - View - Dyno Therapeutics org chart

• Director at IDRx - View - IDRx org chart

• Director at Octant - View - Octant org chart

• Director at Tome Biosciences - View - Tome Biosciences org chart

• Director at Vicinitas Therapeutics - View - Vicinitas Therapeutics org chart

Crear su alerta
para seguir la carrera profesional de Jorge Conde.

Jorge Conde obtuvo un Master of Science in Biomedical Enterprise por Harvard-MIT Division of Health Sciences and Technology y un Master of Business Administration por Harvard Business School.

También han estudiado en Harvard Business School:

• Andrew Wexler - Herschend Enterprises
• Trina Soske - Amazon
• Jeffrey Teper - Microsoft

Encuenttre más ex alumnos de Harvard Business School

Aquí tiene unos consejos para establecer rápidamente un excelente contacto.